Literature DB >> 20873867

Novel surgical approaches for sampling the ovarian surface epithelium and proximal fluid proteome.

Bunja Rungruang1, Brian L Hood, Mai Sun, Ebony Hoskins, Thomas P Conrads, Kristin K Zorn.   

Abstract

The pathogenesis of ovarian, fallopian tube, and peritoneal cancers has been difficult to elucidate despite intense effort. Recently, though, the care of women felt to be at high risk due to a strong family history of breast and/or ovarian cancer or a known germline BRCA1 or BRCA2 mutation has provided potential insight into the development of these malignancies. Risk-reducing surgical removal of the fallopian tubes and ovaries, called risk-reducing bilateral salpingo-oopherectomy (RRBSO), is commonly performed as a laparoscopic procedure to minimize recovery time. We describe here an optimized surgical sampling workflow for analyzing the proteomes of peritoneal, fallopian tube, and ovarian surface epithelial (OSE) specimens collected at the time of laparoscopic RRBSO, a technique which has not been described previously. This methodology presents a unique opportunity for closer examination of the proteomic alterations in the tissues at risk for malignant transformation in women with an inherited susceptibility to ovarian, fallopian tube, and peritoneal cancer development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20873867      PMCID: PMC3190590          DOI: 10.1021/pr100451f

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  17 in total

1.  A model for random sampling and estimation of relative protein abundance in shotgun proteomics.

Authors:  Hongbin Liu; Rovshan G Sadygov; John R Yates
Journal:  Anal Chem       Date:  2004-07-15       Impact factor: 6.986

2.  Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling.

Authors:  Sen-Yung Hsieh; Ren-Kung Chen; Yi-Hsin Pan; Hai-Lun Lee
Journal:  Proteomics       Date:  2006-05       Impact factor: 3.984

3.  Proteome changes in ovarian epithelial cells derived from women with BRCA1 mutations and family histories of cancer.

Authors:  Diana M Smith-Beckerman; Kit W Fung; Katherine E Williams; Nelly Auersperg; Andrew K Godwin; Alma L Burlingame
Journal:  Mol Cell Proteomics       Date:  2004-12-09       Impact factor: 5.911

4.  Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies.

Authors:  H Salazar; A K Godwin; M B Daly; P B Laub; W M Hogan; N Rosenblum; M P Boente; H T Lynch; T C Hamilton
Journal:  J Natl Cancer Inst       Date:  1996-12-18       Impact factor: 13.506

5.  Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations.

Authors:  L Deligdisch; J Gil; H Kerner; H S Wu; D Beck; R Gershoni-Baruch
Journal:  Cancer       Date:  1999-10-15       Impact factor: 6.860

6.  Proteomic analysis of a preneoplastic phenotype in ovarian surface epithelial cells derived from prophylactic oophorectomies.

Authors:  Qing-Yu He; Yuan Zhou; Esther Wong; Thomas G Ehlen; Nelly Auersperg; Jen-Fu Chiu; Alice S T Wong
Journal:  Gynecol Oncol       Date:  2005-07       Impact factor: 5.482

7.  Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.

Authors:  C Bethan Powell; Eric Kenley; Lee-May Chen; Beth Crawford; Jane McLennan; Charles Zaloudek; Miriam Komaromy; Mary Beattie; John Ziegler
Journal:  J Clin Oncol       Date:  2005-01-01       Impact factor: 44.544

8.  Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.

Authors:  Isabelle H Roland; Wan-Lin Yang; Dong-Hua Yang; Mary B Daly; Robert F Ozols; Thomas C Hamilton; Henry T Lynch; Andrew K Godwin; Xiang-Xi Xu
Journal:  Cancer       Date:  2003-12-15       Impact factor: 6.860

9.  Prophylactic oophorectomy: a morphologic and immunohistochemical study.

Authors:  Peter W Schlosshauer; Carmel J Cohen; Frederique Penault-Llorca; Carlos R Miranda; Yves-Jean Bignon; Jacques Dauplat; Liane Deligdisch
Journal:  Cancer       Date:  2003-12-15       Impact factor: 6.860

10.  Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol.

Authors:  Joseph T Rabban; Ellen Krasik; Lee-May Chen; Catherine B Powell; Beth Crawford; Charles J Zaloudek
Journal:  Am J Surg Pathol       Date:  2009-12       Impact factor: 6.394

View more
  6 in total

1.  A multidisciplinary clinic for individualizing management of patients at increased risk for breast and gynecologic cancer.

Authors:  Natalie J Engel; Patricia Gordon; Darcy L Thull; Beth Dudley; Judy Herstine; Rachel C Jankowitz; Kristin K Zorn
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

2.  Ovarian cancer: prevention, detection, and treatment of the disease and its recurrence. Molecular mechanisms and personalized medicine meeting report.

Authors:  Francesmary Modugno; Robert P Edwards
Journal:  Int J Gynecol Cancer       Date:  2012-10       Impact factor: 3.437

3.  New views on the pathogenesis of high-grade pelvic serous carcinoma with suggestions for advancing future research.

Authors:  Mark E Sherman; Richard Guido; Nicolas Wentzensen; Hannah P Yang; Phuong L Mai; Mark H Greene
Journal:  Gynecol Oncol       Date:  2012-08-29       Impact factor: 5.482

4.  Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.

Authors:  Mark E Sherman; Marion Piedmonte; Phuong L Mai; Olga B Ioffe; Brigitte M Ronnett; Linda Van Le; Iouri Ivanov; Maria C Bell; Stephanie V Blank; Paul DiSilvestro; Chad A Hamilton; Krishnansu S Tewari; Katie Wakeley; Noah D Kauff; S Diane Yamada; Gustavo Rodriguez; Steven J Skates; David S Alberts; Joan L Walker; Lori Minasian; Karen Lu; Mark H Greene
Journal:  J Clin Oncol       Date:  2014-09-08       Impact factor: 44.544

Review 5.  Proteomics in cancer biomarkers discovery: challenges and applications.

Authors:  Reem M Sallam
Journal:  Dis Markers       Date:  2015-04-27       Impact factor: 3.434

6.  Human fallopian tube proteome shows high coverage of mesenchymal stem cells associated proteins.

Authors:  Chenyuan Wang; Yang Liu; Cheng Chang; Songfeng Wu; Jie Gao; Yang Zhang; Yingjie Chen; Fan Zhong; Gaopi Deng
Journal:  Biosci Rep       Date:  2016-01-12       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.